期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | SURGICAL ONCOLOGY-OXFORD LetPub Score 6.2
50 ratings
Rate
Reputation 7.6 Influence 4.9 Speed 7.0 | ||||||||||||||||||||
期刊簡稱 | SURG ONCOL | ||||||||||||||||||||
ISSN | 0960-7404 | ||||||||||||||||||||
E-ISSN | 1879-3320 | ||||||||||||||||||||
h-index | 58 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 4.30%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://www.journals.elsevier.com/surgical-oncology/ | ||||||||||||||||||||
在線稿件提交 | http://ees.elsevier.com/surgonc/ | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Elsevier BV | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||
創刊年 | 1992 | ||||||||||||||||||||
每年文章數 | 77每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 12.77% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0960-7404%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) 來自Elsevier的數據: Average 9.1 Week(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 8.5 Week(s) | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[SURGICAL ONCOLOGY-OXFORD] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 16:39:53 評論於 Common types of articles include Article, Letter, Comments, Review, Protocol, and Summary(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 08:46:10 評論於 The Science Citation Index (SCI) was founded in 1957 by the Institute for Scientific Information (ISI) in Philadelphia, USA. It is a citation database published by the ISI in 1961. SCI, EI (Engineering Index), and ISTP (Science and Technology Proceedings) are the world's three famous scientific literature retrieval systems and are internationally recognized as the main tools for scientific statistics and evaluation, with SCI being the most important(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 14:00:38 評論於 What types of articles are there in SCI journals?(0) 讚! | 深渊兴业 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 12:36:54 評論於 What is SCI?(0) 讚! | 八坂篷蔚 |
作者: Dominic Walsh 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-12-15 11:29:18 評論於 Do you require a review fee or a layout fee?(0) 讚! | Dominic Walsh |
作者: 白云友瑶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-10-26 23:36:32 評論於 Excuse me, is the submission a research article or a letter? Is it a total of 9 days, or is it for external review? Thank you!(0) 讚! | 白云友瑶 |
作者: 努力啊大晴霞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-10-15 13:42:49 評論於 Submission accepted within nine days, quickly go live(0) 讚! | 努力啊大晴霞 |
作者: 宫古晓霜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-19 12:15:05 評論於 I have already blacklisted this magazine. The editor is very slow. Submitted on March 4th, not sent for external review, rejected on April 19th. Does it take 45 days to consider a rejection?(0) 讚! | 宫古晓霜 |
作者: 筑阳念烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-02 18:40:41 評論於 Review Speed: 1.0 Experience Sharing: Submitted to a journal on 3/16, not sent for external review. Rejected on 4/2, the editor took 2 weeks to reject, which is quite a long time(0) 讚! | 筑阳念烟 |
作者: 无妄静涵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-07-19 23:00:31 評論於 Review Speed: 1.0 | Submission Acceptance Rate: 50.0 Experience Sharing: Received Date: 13 February 2018 Revised Date: 14 June 2018 Accepted Date: 15 July 2018(0) 讚! | 无妄静涵 |
作者: 无妄静涵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-07-16 11:40:59 評論於 Review speed: 6.0 | Submission success rate: 50.0 Experience sharing: The reviewers are relatively fast, but the editors are slow. It took 5 months for acceptance(0) 讚! | 无妄静涵 |
作者: 盼柳超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-05-22 19:49:56 評論於 The status "Reviewer Invited" has been ongoing for over a month(0) 讚! | 盼柳超级甜 |
作者: 四风傲雪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-01-25 15:55:50 評論於 Do I need to contact the editor in advance? They rejected my submission in four days without giving any reasons. But they were really fast(0) 讚! | 四风傲雪 |
作者: 润发大叔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-12-06 13:10:09 評論於 Review speed: 1.0 | Submission hit rate: 25.0 Experience sharing: The manuscript was rejected directly in four days. No reasons given. The speed was quite fast(0) 讚! | 润发大叔 |
作者: 澄静从菡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-12-27 15:18:49 評論於 Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: The volume of submissions is not large, the review time is moderate, and the quality of articles is acceptable(0) 讚! | 澄静从菡 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-08-03 22:30:15 評論於 This situation should be relatively rare. Our team got two articles in the middle of last year, about 40 days each, and the efficiency feels good, but the quality of the magazine needs to be improved further(0) 讚! | 凌霄高洁 |
作者: 璃沙建强 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-08-01 13:54:57 評論於 Damn it, 3 days decision, knowing the rejection, basically impossible to be accepted. But you keep dragging my manuscript, decision in process for 3 months already, why don't you just reject it, what benefits do you have by dragging someone else's manuscript? Sending emails is just polite words waiting for the editor-in-chief's decision, I'm so damn angry(0) 讚! | 璃沙建强 |
作者: 黯然涵真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-03-11 12:08:51 評論於 Review Speed: 2.0 | Submission Acceptance Rate: 75.0 Experience Sharing: Mainly accept meta and review articles, which are more likely to be accepted(0) 讚! | 黯然涵真 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 14:50:27 評論於 Bullish, if it goes up again tomorrow, it might break through 3 points(0) 讚! | 凌霄高洁 |
作者: 太山俊美 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-28 17:00:23 評論於 Research Focus: Tumors; Cancer(0) 讚! | 太山俊美 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us